|
시장보고서
상품코드
2020704
암등록 시스템 소프트웨어 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Cancer Registry Software Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
암등록 소프트웨어 시장 규모는 2025년 1억 218만 달러에서 2026-2034년에 CAGR 12.84%로 성장하며, 2034년에는 3억 305만 달러에 달할 것으로 예측됩니다.
전 세계 암 등록 소프트웨어 시장은 암 유병률의 증가와 의료 분야의 효율적인 데이터 관리 시스템의 필요성으로 인해 괄목할 만한 성장세를 보이고 있습니다. 암 등록 소프트웨어는 의료 기관이 환자 데이터를 수집, 저장, 분석하여 더 나은 질병 모니터링 및 조사를 수행하는 데 도움이 됩니다. 정부와 의료 기관은 암 발생 상황을 추적하고 치료 계획을 개선하기 위해 이러한 시스템을 점점 더 많이 도입하고 있습니다.
의료 데이터 분석과 디지털 헬스 솔루션에 대한 관심이 높아지는 것도 시장 수요를 더욱 부추기고 있습니다. 암 등록 소프트웨어는 역학 조사의 질을 향상시키고, 임상적 의사결정을 지원하며, 암 사례의 추세를 파악하는 데 도움이 됩니다. 또한 의료 IT 인프라에 대한 투자 증가와 암 감시 프로그램을 추진하는 정부의 노력도 시장 성장에 기여하고 있습니다.
향후 수년간 인공지능(AI) 및 클라우드 기반 기술과의 통합을 통해 암 등록 시스템의 기능이 강화될 것으로 예상됩니다. 이러한 발전은 데이터의 정확성, 접근성 및 실시간 분석을 향상시킬 것입니다. 암 연구, 조기 발견 및 국민 헬스케어에 대한 전 세계적인 관심 증가는 앞으로도 이 시장에 강력한 성장 기회를 제공할 것입니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 암등록 시스템 소프트웨어 시장 : 소프트웨어별
제5장 세계의 암등록 시스템 소프트웨어 시장 : 배포 모델별
제6장 세계의 암등록 시스템 소프트웨어 시장 : 컴포넌트별
제7장 세계의 암등록 시스템 소프트웨어 시장 : 최종 사용별
제8장 세계의 암등록 시스템 소프트웨어 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSA 26.05.11The Cancer Registry Software Market size is expected to reach USD 303.05 Million in 2034 from USD 102.18 Million (2025) growing at a CAGR of 12.84% during 2026-2034.
The global cancer registry software market is witnessing notable growth due to the increasing prevalence of cancer and the need for efficient data management systems in healthcare. Cancer registry software helps healthcare organizations collect, store, and analyze patient data for better disease monitoring and research. Governments and healthcare institutions are increasingly adopting such systems to track cancer incidence and improve treatment planning.
The growing emphasis on healthcare data analytics and digital health solutions is further driving market demand. Cancer registry software enables better epidemiological research, supports clinical decision-making, and assists in identifying trends in cancer cases. Additionally, rising investments in healthcare IT infrastructure and government initiatives promoting cancer surveillance programs are contributing to market growth.
In the coming years, the integration of artificial intelligence and cloud-based technologies is expected to enhance the capabilities of cancer registry systems. These advancements will improve data accuracy, accessibility, and real-time analysis. Increasing global focus on cancer research, early detection, and population health management will continue to create strong growth opportunities for this market.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Software
- Standalone
- Integrated
By Deployment Model
- On-premise
- Cloud Based
By Component
- Commercial
- Public
By End-use
- Government & Third Party
- Private Payers
- Hospital & Medical Practice
- Pharma Biotech & Medical Device Companies
- Research Institutes
COMPANIES PROFILED
- Elekta AB, Oracle Corporation, ONCO Inc, International Business Machines Corporation IBM, McKesson Corporation, Conduent Incorporated, Ordinate Corporation, Volpara Health Technologies Limited, Health Catalyst Inc, Rocky Mountain Cancer Data Systems University of Utah Health
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY SOFTWARE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Software
- 4.2. Standalone Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Integrated Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY DEPLOYMENT MODEL 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Deployment Model
- 5.2. On-premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Cloud Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY COMPONENT 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Component
- 6.2. Commercial Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY END-USE 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End-use
- 7.2. Government & Third Party Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Private Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Hospital & Medical Practice Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Pharma Biotech & Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.6. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY REGION 2022-2034 (USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Software
- 8.2.2 By Deployment Model
- 8.2.3 By Component
- 8.2.4 By End-use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Software
- 8.3.2 By Deployment Model
- 8.3.3 By Component
- 8.3.4 By End-use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Software
- 8.4.2 By Deployment Model
- 8.4.3 By Component
- 8.4.4 By End-use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Software
- 8.5.2 By Deployment Model
- 8.5.3 By Component
- 8.5.4 By End-use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Software
- 8.6.2 By Deployment Model
- 8.6.3 By Component
- 8.6.4 By End-use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL CANCER REGISTRY SOFTWARE INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Elekta AB
- 10.2.2 Oracle Corporation
- 10.2.3 ONCO Inc
- 10.2.4 International Business Machines Corporation (IBM)
- 10.2.5 McKesson Corporation
- 10.2.6 Conduent Incorporated
- 10.2.7 Ordinate Corporation
- 10.2.8 Volpara Health Technologies Limited
- 10.2.9 Health Catalyst Inc
- 10.2.10 Rocky Mountain Cancer Data Systems (University Of Utah Health)
